跳至主要内容
临床试验/NCT04781010
NCT04781010Unknown不适用

Characterization and Outcome of Children With Leukodystrophy: An Observational Study at Sohag University Hospital

Sohag University0 个研究点目标入组 100 人开始时间: 2021年3月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
主要终点
Biochemical changes

研究概览

简要总结

Leukodystrophies are heterogeneous genetic disorders characterized by the selective involvement of white matter in the central nervous system (CNS) (1, 2). Inherited leukodystrophies are diseases of the myelin, including abnormal myelin development, hypomyelination, or degeneration of myelin (3, 4).

Most of these disorders fall into one of three categories; lysosomal storage diseases, peroxisomal disorders, and diseases caused by mitochondrial dysfunction and each leukodystrophy has distinctive clinical, biochemical, pathologic, and radiologic features (5).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
0 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • The patients fulfilling all the following criteria will be included:
  • Age ≤ 18 years.
  • The presence of typical clinical, biochemical, and neuroimaging features of leukodystrophies.

排除标准

  • 1- Children who have coexistent genetic disorders. 2- Children who have cerebral malformations. 3- History of perinatal asphyxia. 4- History of head trauma or intracranial hemorrhage. 5- Acquired CNS myelin disorders, such as multiple sclerosis and related acquired demyelinating processes, infectious and post-infectious white matter damage, toxic injuries and non-genetic vascular insults.

结局指标

主要结局

Biochemical changes

时间窗: 2 years

1. Arylsulfatase A levels can be measured in the leukocytes if suspected Metachromatic Leukodystrophy. 2. Galactocerebrosidase (GALC) enzyme level for Krabbe's Disease. 3. Plasma VLCFAs for Adrenoleukodystrophy. 4. NAA levels in the urine for Canavan's Disease. 5. Beta galactosidase in leukocytes deficient in cases of infantile GM1 gangliosidosis \&Hexosaminidase for Tay Sachs disease. 6. Plasma FSH ,LH markedly reduced in cases of 4 H (Hypomyelination, hypodontia and hypogonadotropic hypogonadism syndrome). 7. Genetic testing for certain diseases

White matter changes in MRI

时间窗: 2 years

Brain MRI of all patients will be systematically reviewed, particularly Sagittal T1, Axial T1, T2-weighted and fluid-attenuated inversion-recovery (FLAIR) sequences. Other sequences will be also reviewed if available, such as MR spectroscopy (MRS) (for mitochondrial disorders or Canavan disease to investigate abnormalities in lactate or N-acetyl aspartate (NAA) respectively), and diffusion-weighting (useful in disorders such as AARS2-related leukoencephalopathy).

次要结局

  • Urinary organic acid analysis(2 years)
  • Electrophysiological changes(2 years)
  • Tandem mass spectrometry (MS/MS) finding(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nagat Mohamed Shehata

assistant specialist

Sohag University

相似试验